Table 3.
Association of the Biomarker With the Treatment Outcomes at Baseline
Univariate Model | Multivariate Model | |||
---|---|---|---|---|
Marker | OR (95% CI) | P Value | Adjusted ORa (95% CI) | P Value |
CCL2 | 1.26 (1.03–1.54) | .025 | 1.26 (1.02–1.56) | .035 |
CCL3 | 4.41 (2.84–6.83) | <.001 | 4.89 (2.99–7.99) | <.001 |
CCL4 | 1.30 (1.11–1.52) | .001 | 1.36 (1.15–1.61) | <.001 |
CCL5 | 1.17 (.84–1.62) | .351 | 1.18 (.83–1.66) | .359 |
CCL11 | 0.89 (.69–1.14) | .357 | 0.89 (.69–1.17) | .407 |
CCL19 | 1.18 (.96–1.45) | .109 | 1.18 (.95–1.46) | .142 |
CCL20 | 0.97 (.77–1.21) | .775 | 0.97 (.77–1.23) | .830 |
CXCL1 | 0.50 (.37–.67) | <.001 | 0.45 (.33–.63) | <.001 |
CXCL8 | 2.71 (1.99–3.68) | <.001 | 2.84 (2.05–3.92) | <.001 |
CXCL10 | 2.91 (2.10–4.03) | <.001 | 2.95 (2.10–4.15) | <.001 |
CX3CL1 | 1.65 (1.14–2.38) | .008 | 1.70 (1.15–2.53) | .008 |
Abbreviations: CI, confidence interval; OR, odds ratio.
aMultivariate logistic regression models study the association of biomarker with treatment outcomes (unfavorable) and are adjusted for age in years, gender, body mass index, diabetes status, smoking status, alcohol status, and smear grading.